Navigation Links
Martek Announces Third Quarter 2007 Financial Results
Date:9/5/2007

e subject to quarter-to-quarter fluctuations, some of which may be significant. The forward-looking statements noted above are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors and cautionary statements set forth herein and in the Company's filings with the Securities and Exchange Commission, including, but not limited to, Part I, Item 1A of the Company's Form 10-K/A for the fiscal year ended October 31, 2006 and other filed reports on Form 10-K, Form 10-Q, Form 10-Q/A and Form 8-K.

About Martek

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.

CONTACT

Kyle Stults

Investor Relations

(410) 740-0081

kstults@martek.com

MARTEK BIOSCIENCES CORPORATION

Summary Consolidated Financial Information

(Unaudited - $ in thousands, except share and per share data)

Condensed Consolidated Statements of Income Data

Three months ended July 31, Nine months ended July 31,

2007 2006 2
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. PM announces a new health care order for India
2. PowderMed Announces Needle-Less Flu Vaccine
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
9. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...RNewswire-FirstCall/ -- ViroPharma Incorporated,(...submitted a supplemental,Biologics License Applic...ion,(FDA) for Cinryze(TM) C1 Inhibitor (human) as...oedema (HAE). , The sBLA is based on a re-a...hase 3 acute treatment study of Cinryze and interi...
(Date:12/1/2008)...PRNewswire/ -- Media entrepreneur, television and,... and philanthropist John,Bendheim will be honored...annual "Road To A Cure" Gala, December 2, 2008, at...ell, Chairman of the Board of Governors, co-chairs...an and Fran Solomon. The "Road To,A Cure" Gala i...
(Date:12/1/2008)..., personality illnesses common, study shows , ...atric disorders are common among young adults in t...port shows. , To reach this finding, U.S. resea...nts, aged 19 to 25, who took part in the National ...ions. , The study found that 45.8 percent of th...
(Date:12/1/2008)...with the agency,s goals, commitment and resources ... Responding to criticism that it has done a poor j... Food and Drug Administration released a report Mo..., Among the most important changes in 2008 was t...ps with state and local health departments to prot...
Breaking Medicine News(10 mins):Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5Health News:Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual 'Road To A Cure' Gala 2Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4
...s Aureus, or MRSA, a type of bacteria resistant to...ic health; it spreads through// direct contact and...eople. This infection is thought to be dormant ...o apparent signs of sickness, which makes it all t...
...ed in two more districts in Cambodia's eastern pro... 3000 ducks have died in the last week.// "We hav...t has not infected the people yet," Kao Phal, the ...the agriculture ministry, told AFP on Friday. "Th...
...e to alleged negligence by doctors, attacked the m...pital Sunday// in the coastal city of Visakhapatna...cer were injured in the attack while six doctors a...ospital for safety. Tension prevailed at the hosp...
... the Mahim beach to drink sweet seawater for the s...d people against drinking// the polluted water. S...weet due to the natural phenomenon of dilution. "...bserved all along the western coast of India durin...
Other Medicine News:Health News:Maharashtra warns against Mahim's 'miracle' water 2
(Date:11/27/2008)...ty of acute lymphoblastic leukemia relapse cases a...agnosis , , MEMPHIS, Tenn., Nov. 27 /PRNews...n,s Research Hospital have identified distinctive ...th acute lymphoblastic leukemia (ALL) that cause r...treatments for ALL relapse in children and, ultima...
(Date:11/25/2008)...PRNewswire-USNewswire/ -- Kleinert Kutz and Unive...ifth U.S. hand transplant on Messina, New York res... Hospital Hand Care Center on Monday, November 24....as completed shortly after 9 p.m. in a record nine...m/cgi-bin/prnh/20081125/DC48555-a ) , (Photo: ...
(Date:11/25/2008)...linical Trial to Assess Survival of Patients Recei...resectable Hepatocellular Carcinoma , , BEL...es Oncology, Inc. (LSO) today announced the comple...ial of Light Infusion Therapy(TM) (Litx(TM)) as a ...a (HCC), also known as hepatoma or primary liver c...
(Date:11/24/2008)...cer Awareness Month , , Oak Brook, Ill., No...iety for Gastrointestinal Endoscopy (ASGE) and the...his November to raise awareness about pancreatic c...e resources that are available for them. , , ... cancer deaths in the U.S. In 2008, an estimated 3...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Nano sized trojan horse to aid nutrition 7318 1Nano sized trojan horse to aid nutrition 7318 2Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues 25769 1Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues 25769 2Lilly and Amylin Set Date and Time for Conference Call 25766 1Lilly and Amylin Set Date and Time for Conference Call 25766 2Duke Medicine physician scientist receives National Medal of Science 4605 1Duke Medicine physician scientist receives National Medal of Science 4605 2Duke Medicine physician scientist receives National Medal of Science 4605 3
...E)--Jun 26, 2007 - Acceleron Pharma,Inc., a bioph...he,treatment of musculoskeletal, metabolic and can...nstrating that ACE-011, a,novel anabolic bone agen...ass and architecture in a murine model of multiple...ma cells in the bone marrow,that disrupts normal b...
...d Immune Globulin Study Uncovers Sample,Manipulati...wire-USNewswire/ -- An analysis,released today cri... ruling out a link between autism and Rh immune gl...the mercury-based,preservative thimerosal. Besides...nipulation of the study sample, so that,earlier da...
Other Medicine Technology:ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 2ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model 3Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
Increase profitability by reducing chair time with simple test,sequences that can be administered by ancillary office staff in,less than 5 minutes. New Unsurpassed Homogenous Illumination.,Back
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking.
Pediatric: Tumbling "E" Acuity, Binocular Balance, Supression, Fixation Disparity, Stereopsis
Child Acuity: Allen, Tumbling E, and Landolt C Tests.
Medicine Products: